Cargando…
Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway
BACKGROUND: Epiplakin1 (EPPK1) has been associated with disease progression and unfavorable prognosis of many cancers, but its functional involvement in esophageal squamous cell carcinoma (ESCC) remains to be uncovered. METHODS: The Quantitative Real‐time PCR (qPCR) assay was employed to determine t...
Autores principales: | Qiao, Zhongshi, Dai, Chengcheng, Wang, Zhiqian, Wang, Zifan, Wang, Zheng, Zhang, Tongsong, Niu, Wenjing, Ma, Xuezhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013648/ https://www.ncbi.nlm.nih.gov/pubmed/35238170 http://dx.doi.org/10.1111/1759-7714.14366 |
Ejemplares similares
-
Effects of epiplakin-knockdown in cultured corneal epithelial cells
por: Kokado, Masahide, et al.
Publicado: (2016) -
Comparative genomics reveals evolutionary loss of epiplakin in cetaceans
por: Fuchs, Peter, et al.
Publicado: (2022) -
Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer
por: Shimura, Soichiro, et al.
Publicado: (2021) -
Epiplakin attenuates experimental mouse liver injury by chaperoning keratin reorganization
por: Szabo, Sandra, et al.
Publicado: (2015) -
ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway
por: Yin, Hui, et al.
Publicado: (2020)